Andrew Wang, MD

Professor of Medicine
Vice Chief for Clinical Services
Campus mail Duke Box 3428, Durham, NC 27710
Phone (919) 681-1370

Structural heart diseases, including valvular heart disease, hemodynamics, infective endocarditis, and hypertrophic cardiomyopathy

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1995 - 1997
  • Assistant Chief of Service, Medicine, Johns Hopkins University, 1994 - 1995
  • Fellow in Cardiology, Medicine, Duke University, 1993 - 1994
  • Medical Resident, Medicine, Johns Hopkins University, 1990 - 1993
  • M.D., Duke University, 1990

Publications

Wang, Andrew, and Emil L. Fosbøl. “Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines.” Eur Heart J 43, no. 17 (May 1, 2022): 1617–25. https://doi.org/10.1093/eurheartj/ehab898.

PMID
35029274
Full Text

Bishawi, Muath, Carmelo Milano, Jeffrey Gaca, Keith Carr, Andrew Wang, and Donald D. Glower. “The outcome of mitral repair for degenerative versus ischemic mitral regurgitation using a single complete ring.” J Card Surg 37, no. 2 (February 2022): 290–96. https://doi.org/10.1111/jocs.16094.

PMID
34665478
Full Text

Hegde, Sheila M., Steven J. Lester, Scott D. Solomon, Michelle Michels, Perry M. Elliott, Sherif F. Nagueh, Lubna Choudhury, et al. “Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.” J Am Coll Cardiol 78, no. 25 (December 21, 2021): 2518–32. https://doi.org/10.1016/j.jacc.2021.09.1381.

PMID
34915982
Full Text

Bishawi, Muath, Carmelo Milano, Jeffrey Gaca, Andrew Wang, Keith Carr, and Donald D. Glower. “Late Durability of Mitral Repair for Ischemic Versus Nonischemic Functional Mitral Regurgitation.” Ann Thorac Surg, September 20, 2021. https://doi.org/10.1016/j.athoracsur.2021.08.021.

PMID
34547301
Full Text

Saberi, Sara, Nuno Cardim, Mohamad Yamani, Jeanette Schulz-Menger, Wanying Li, Victoria Florea, Amy J. Sehnert, et al. “Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis.” Circulation 143, no. 6 (February 9, 2021): 606–8. https://doi.org/10.1161/CIRCULATIONAHA.120.052359.

PMID
33190524
Full Text

Quintana, Eduard, Pietro Bajona, and Patrick O. Myers. “Mavacamten for hypertrophic obstructive cardiomyopathy.” Lancet 397, no. 10272 (January 30, 2021): 369. https://doi.org/10.1016/S0140-6736(20)32384-9.

PMID
33516331
Full Text

Olivotto, Iacopo, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, et al. “Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.” Lancet 396, no. 10253 (September 12, 2020): 759–69. https://doi.org/10.1016/S0140-6736(20)31792-X.

PMID
32871100
Full Text

Abdulrahim, Jawan W., Lydia Coulter Kwee, Fawaz Alenezi, Albert Y. Sun, Aris Baras, Teminioluwa A. Ajayi, Ricardo Henao, et al. “Identification of Undetected Monogenic Cardiovascular Disorders.” J Am Coll Cardiol 76, no. 7 (August 18, 2020): 797–808. https://doi.org/10.1016/j.jacc.2020.06.037.

PMID
32792077
Full Text

Ho, Carolyn Y., Matthew E. Mealiffe, Richard G. Bach, Mondira Bhattacharya, Lubna Choudhury, Jay M. Edelberg, Sheila M. Hegde, et al. “Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.” J Am Coll Cardiol 75, no. 21 (June 2, 2020): 2649–60. https://doi.org/10.1016/j.jacc.2020.03.064.

PMID
32466879
Full Text

Pineda, Andrés M., Jennifer Rymer, Alice Wang, Adam Z. Banks, Lynne H. Koweek, Ryan Plichta, Adam Williams, et al. “Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.” Am Heart J 224 (June 2020): 105–12. https://doi.org/10.1016/j.ahj.2020.02.003.

PMID
32361278
Full Text

Pages